ABAlexandra Beling

Alexandra Beling

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Alexandra Beling has a total of 20 co-authors. Here are the top co-authors by number of shared publications:

  • Adam Sebastian Tenforde

    Department of Physical Medicine and Rehabilitation, Harvard Medical School/Spaulding Rehabilitation Hospital, Boston, Massachusetts, USA

    2 shared publications
  • Alexander Pomerantz

    Boston University, Department of Family Medicine, Boston, MA, USA

    1 shared publication
  • Amol Saxena

    Department of Sports Medicine, Sutter-Palo Alto Medical Foundation , 795 El Camino Real, Palo Alto, CA 94301

    1 shared publication
  • Daniel J. Hedequist

    Department of Orthopedics, Boston Children’s Hospital, Boston, USA

    1 shared publication
  • Douglas Comeau

    Boston University, Department of Family Medicine, Boston, MA, USA; Boston College, Murray Center for Student Wellness, Division of Student Affairs 140 Commonwealth Avenue, Chestnut Hill, MA 02467, USA

    1 shared publication
  • Hye Chang Rhim

    Department of Physical Medicine and Rehabilitation, Harvard Medical School, Spaulding Rehabilitation Hospital, Boston, MA 02115, USA

    1 shared publication

Latest Publications

  • Concussion in contact sport: risks, detection, & prevention

    by Alexander Pomerantz, Alexandra G. Beling, Douglas Comeau

  • Extracorporeal Shockwave Therapy for Greater Trochanteric Pain Syndrome

    by Hye Chang Rhim, Jaehyung Shin, Alexandra Beling, Raymond Guo, Xiaoyu Pan, Wilma Afunugo, Joseph Ruiz, Michael N. Andrew, James Kim, Adam S. Tenforde

    Background: Greater trochanteric pain syndrome (GTPS) affects 17.6% of adults aged 50 to 79 years, particularly women. While exercise therapy and corticosteroid injections (CSIs) are common treatments, their limitations include inadequate pain control and potential tendon weakening. Extracorporeal shockwave therapy (ESWT) is an emerging alternative for GTPS. This systematic review assessed ESWT's efficacy in GTPS by evaluating pain and functional outcomes at different follow-up intervals. Methods: A literature search of PubMed, Embase, and Web of Science for randomized clinical trials (RCTs) was conducted comparing ESWT with other GTPS treatments up to March 1, 2024. Two reviewers independently extracted data, assessing study quality using the Cochrane risk-of-bias tool. A random-effects pairwise meta-analysis compared ESWT with other treatments. Results: Eight RCTs involving 754 patients (169 male, 585 female patients) were included. Seven RCTs were deemed high risk of bias, and 1 RCT had some concerns. Five RCTs investigated focused on focused ESWT, and 3 examined radial ESWT. ESWT provided significantly lower pain scores than other treatments at 2 to 4 months (standardized mean difference = −0.431; 95% confidence interval [CI], −0.82 to −0.039; I2 = 83%). Functional improvement (Lower Extremity Functional Scale) was significantly higher at 6 months (weighted mean difference = 6.68; 95% CI, 3.11-10.25; I2 = 0%) but did not exceed the minimal clinically important difference. Focused ESWT provided greater pain reduction than radial ESWT. Conclusion: Three weekly ESWT sessions offer short-term pain relief at 2 to 4 months for patients with GTPS, especially with focused ESWT. Functional improvements at 6 months were notable but not clinically significant. These findings suggest ESWT may complement or serve as an alternative to CSIs and exercise. However, caution is needed when interpreting these results due to high risk of bias with the included RCTs and heterogeneity across the studies. Further high-quality trials are needed to confirm ESWT's long-term benefits over other treatments. Level of Evidence: Level II. See Instructions for Authors for a complete description of levels of evidence.


  • Open Access

    Outcomes Using Focused Shockwave for Treatment of Bone Stress Injury in Runners

    by Alexandra Beling, Amol Saxena, Karsten Hollander, Adam S. Tenforde

    Bone stress injury (BSI) is a common overuse injury that can result in prolonged time away from sport. Limited studies have characterized the use of extracorporeal shockwave therapy (ESWT) for the treatment of BSI. The purpose of this study was to describe the use of ESWT for the management of BSI in runners. A retrospective chart review was performed to identify eligible patients in a single physician’s clinic from 1 August 2018 to 30 September 2022. BSI was identified in 40 runners with 41 injuries (28 females; average age and standard deviation: 30 ± 13 years; average pre-injury training 72 ± 40 km per week). Overall, 63% (n = 26) met the criteria for moderate- or high-risk Female or Male Athlete Triad categories. Runners started ESWT at a median of 36 days (IQR 11 to 95 days; range 3 days to 8 years) from BSI diagnosis. On average, each received 5 ± 2 total focused ESWT treatments. Those with acute BSI (ESWT started 3 months, n = 3) or non-union (>6 months, n = 9) had longer time for return to running (19.8 ± 14.8 weeks, p = 0.032). All runners returned to pain-free running after ESWT except one runner with non-union of grade 4 navicular BSI who opted for surgery. No complications were observed with ESWT. These findings suggest that focused ESWT may be a safe treatment for the management of BSI in runners.


  • Vitamin D levels and pain outcomes in adolescent idiopathic scoliosis patients undergoing spine fusion

    by Alexandra Beling, M. Timothy Hresko, Leah DeWitt, Patricia E. Miller, Sarah A. Pitts, John B. Emans, Daniel J. Hedequist, Michael P. Glotzbecker

    Purpose Prior research has indicated adolescent idiopathic scoliosis (AIS) patients have lower bone mineral density and lower vitamin D levels than healthy peers. Vitamin D deficiency has been associated with higher levels of pain. This study investigated whether vitamin D-deficient AIS patients had higher pain before or immediately after posterior spine fusion (PSF) surgery. Methods 25-Hydroxy vitamin D levels were tested in all AIS patients at their pre-operative appointment. Patients were grouped by serum 25-hydroxy vitamin D level: deficient, < 20 ng/mL; insufficient, 20–29 ng/mL; sufficient, ≥ 30 ng/mL. Primary outcomes included pre-operative Scoliosis Research Society Health-Related Quality of Life (SRS-30) and numeric rating scale (NRS) scores (0–10) up to 72 h post-operatively, and analyzed using ANOVA and linear mixed modeling, respectively. 176 patients undergoing PSF were included. Intra-operative characteristics by vitamin D status were also assessed. The cohort was 82% female and an average of 15.2 years (range 10.6–25.3 years) at fusion. Average major curve was 60 (range 40–104) degrees pre-operatively. Results Forty-five (26%) patients were deficient in vitamin D, 75 (43%) were insufficient, and 56 (32%) were sufficient. Patients with vitamin D deficiency had lower average household income by zip code (p < 0.01) and higher secondhand smoke exposure (p < 0.001). There were no differences in pre-operative SRS-30 score, pre- and post-operative major curve angles, or estimated blood loss across vitamin D groups. Trajectories of NRS indicated no differences in pain during the first 72 h after surgery. Conclusion Vitamin D deficiency in this population is associated with potential markers of lower socioeconomic status; however, it does not influence AIS PSF patients’ experience of pain before or immediately after spine fusion surgery. Level of evidence II.